| P50 | author | Thomas W Smith | Q61847239 |
| P2093 | author name string | Sherif F El-Khamisy | |
| | Michael P Williamson | |
| | Robert K Poole | |
| | Peter J F Henderson | |
| | Michael Hippler | |
| | Clare R Trevitt | |
| | Hannah M Southam | |
| | Chunyan Liao | |
| | Francesca L Cox | |
| | Jonathan A Chapman | |
| | Laurence A Middlemiss | |
| | Rhiannon L Lyon | |
| P2860 | cites work | BioNumbers--the database of key numbers in molecular and cell biology | Q24643881 |
| | CORM-3 reactivity toward proteins: the crystal structure of a Ru(II) dicarbonyl-lysozyme complex | Q27666448 |
| | A contribution to the rational design of Ru(CO)3Cl2L complexes for in vivo delivery of CO | Q27696216 |
| | The NO-responsive hemoglobins of Campylobacter jejuni: concerted responses of two globins to NO and evidence in vitro for globin regulation by the transcription factor NssR. | Q29346554 |
| | Metal carbonyls as pharmaceuticals? [Ru(CO)3Cl(glycinate)], a CO-releasing molecule with an extensive aqueous solution chemistry | Q31107951 |
| | Clonogenic assay of cells in vitro. | Q34615431 |
| | Use of carbon monoxide as a therapeutic agent: promises and challenges | Q34752105 |
| | Severe zinc depletion of Escherichia coli: roles for high affinity zinc binding by ZinT, zinc transport and zinc-independent proteins | Q34976588 |
| | The bactericidal activity of carbon monoxide-releasing molecules against Helicobacter pylori | Q35080203 |
| | Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo | Q35525303 |
| | Bioactivity and pharmacological actions of carbon monoxide-releasing molecules | Q35552289 |
| | Spontaneous CO release from Ru(II)(CO)2-protein complexes in aqueous solution, cells, and mice | Q35863628 |
| | Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice | Q36183586 |
| | Involvement of gamma-glutamyl peptides in osmoadaptation of Escherichia coli | Q36256837 |
| | Occurrence of glutathione in bacteria | Q36418603 |
| | Ruthenium complexes as anticancer agents | Q36447238 |
| | Antimicrobial Activity of the Manganese Photoactivated Carbon Monoxide-Releasing Molecule [Mn(CO)3(tpa-κ(3)N)](+) Against a Pathogenic Escherichia coli that Causes Urinary Infections | Q36925719 |
| | Carbon Monoxide Gas Is Not Inert, but Global, in Its Consequences for Bacterial Gene Expression, Iron Acquisition, and Antibiotic Resistance | Q37040059 |
| | Towards improved therapeutic CORMs: understanding the reactivity of CORM-3 with proteins | Q37897587 |
| | Developing drug molecules for therapy with carbon monoxide. | Q37986364 |
| | A role for reactive oxygen species in the antibacterial properties of carbon monoxide-releasing molecules. | Q38024824 |
| | Using chemical shift perturbation to characterise ligand binding | Q38130403 |
| | CO-releasing Metal Carbonyl Compounds as Antimicrobial Agents in the Post-antibiotic Era. | Q38521451 |
| | The Microbiology of Ruthenium Complexes | Q38649194 |
| | Examining the antimicrobial activity and toxicity to animal cells of different types of CO-releasing molecules | Q38811481 |
| | Biological signaling by carbon monoxide and carbon monoxide-releasing molecules | Q39080342 |
| | Aspects of Carbon Monoxide in Form of CO-Releasing Molecules Used in Cancer Treatment: More Light on the Way. | Q39175509 |
| | Cell damage following carbon monoxide releasing molecule exposure: implications for therapeutic applications. | Q39407797 |
| | Analysis of the bacterial response to Ru(CO)3Cl(Glycinate) (CORM-3) and the inactivated compound identifies the role played by the ruthenium compound and reveals sulfur-containing species as a major target of CORM-3 action | Q39454958 |
| | Cardioprotection by hypoxia-inducible factor 1 alpha transfection in skeletal muscle is dependent on haem oxygenase activity in mice | Q39889877 |
| | A carbon monoxide-releasing molecule (CORM-3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia | Q39903621 |
| | CO-Releasing Molecules Have Nonheme Targets in Bacteria: Transcriptomic, Mathematical Modeling and Biochemical Analyses of CORM-3 [Ru(CO)3Cl(glycinate)] Actions on a Heme-Deficient Mutant of Escherichia coli | Q41362779 |
| | Gaseous Mediators and Mitochondrial Function: The Future of Pharmacologically Induced Suspended Animation? | Q41819432 |
| | Cytochrome bd-I in Escherichia coli is less sensitive than cytochromes bd-II or bo'' to inhibition by the carbon monoxide-releasing molecule, CORM-3: N-acetylcysteine reduces CO-RM uptake and inhibition of respiration. | Q41901853 |
| | Ru(CO)3Cl(Glycinate) (CORM-3): a carbon monoxide-releasing molecule with broad-spectrum antimicrobial and photosensitive activities against respiration and cation transport in Escherichia coli | Q42037077 |
| | Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule | Q42169432 |
| | Protection against cisplatin-induced nephrotoxicity by a carbon monoxide-releasing molecule | Q42486556 |
| | Reactive oxygen species mediate bactericidal killing elicited by carbon monoxide-releasing molecules | Q42841026 |
| | Sulfite species enhance carbon monoxide release from CO-releasing molecules: implications for the deoxymyoglobin assay of activity. | Q44087300 |
| | Transcriptional responses of Escherichia coli to S-nitrosoglutathione under defined chemostat conditions reveal major changes in methionine biosynthesis | Q45221652 |
| | In vitro and in vivo effects of the carbon monoxide-releasing molecule, CORM-3, in the xenogeneic pig-to-primate context. | Q46037822 |
| | Exploring the antimicrobial action of a carbon monoxide-releasing compound through whole-genome transcription profiling of Escherichia coli | Q46107296 |
| | Interaction of the carbon monoxide-releasing molecule Ru(CO)3Cl(glycinate) (CORM-3) with Salmonella enterica serovar Typhimurium: in situ measurements of carbon monoxide binding by integrating cavity dual-beam spectrophotometry | Q50425230 |
| | Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. | Q53674243 |
| | Carbon monoxide-releasing antibacterial molecules target respiration and global transcriptional regulators. | Q54412235 |
| | New insights into the chemistry of fac-[Ru(CO)3]2+ fragments in biologically relevant conditions: The CO releasing activity of [Ru(CO)3Cl2(1,3-thiazole)], and the X-ray crystal structure of its adduct with lysozyme | Q58326608 |
| | Differential Antibacterial Activity Against Pseudomonas aeruginosa by Carbon Monoxide-Releasing Molecules | Q61837655 |
| | Analysis in vivo of antitumor activity, cytotoxicity and Interaction between plasmid DNA and the cis-dichloro-tetra-amine-ruthenium(III) chloride | Q79972288 |
| | Syntheses and evaluation of drug-like properties of CO-releasing molecules containing ruthenium and group 6 metal | Q87164363 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 114-123 | |
| P577 | publication date | 2018-09-01 | |
| P1433 | published in | Redox Biology | Q27724751 |
| P1476 | title | A thiol-reactive Ru(II) ion, not CO release, underlies the potent antimicrobial and cytotoxic properties of CO-releasing molecule-3 | |
| P478 | volume | 18 | |